Company: FTII
Filing Date: 2025-04-09
Form Type: 10-K
Source: 0001641172-25-003384
Chunk: 141

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-04-09
Form: 10-K
Item: Item 9C
Chunk 141
---
 2025
  
    Jeffrey
    Moseley

40

EXHIBIT
INDEX

    Exhibit
    No.
     
    Description

    1.1
     
    Underwriting Agreement, dated February 15, 2022, between the Company and EF Hutton, division of Benchmark Investments, LLC, as representative of the underwriters named therein (incorporated by reference to Exhibit 1.1 to the Company’s Form 8-K (File No. 001-41289), filed with the SEC on February 24, 2022)
  
    2.1+
     
    Agreement and Plan of Merger, dated September 16, 2024 by and among FutureTech II Acquisition Corp., Longevity Biomedical, Inc., LBI Merger Sub, Inc., and Bradford A. Zakes (in his capacity as Seller Representative) (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K (File No. 001-41289), filed with the SEC on September 20, 2024)

    3.1
     
    Amended and Restated Certificate of Incorporation, dated February 17, 2022 (2)
  
    3.2
     
    Certificate of Amendment to the Amended and Restated Certificate of Incorporation, dated August 17, 2023 (3)
  
    3.3
     
    Certificate of Amendment to the Amended and Restated Certificate of Incorporation, dated February 14, 2024 (4)
  
    3.4
     
    Certificate of Amendment to the Amended and Restated Certificate of Incorporation, dated November 18, 2024 (5)
  
    3.5
     
    Bylaws. (1)
  
    4.1
     
    Specimen Unit Certificate. (1)
  
    4.2
     
    Specimen Class A Common Stock Certificate. (1)
  
    4.3
     
    Specimen Warrant Certificate. (1)
  
    4.4
     
    Warrant Agreement, dated February 18, 2022, between the Company and Continental Stock Transfer & Trust Company. (2)
  
    4.5
     
    Description of Registered Securities.*
  
    10.1
     
    Letter Agreement, dated February 16, 2022,